Obese children, teens on metformin show reduced BMI

11/27/2012 | Healio

Obese children and adolescents with hyperinsulinemia and/or impaired fasting glucose or impaired glucose tolerance who took metformin daily for six months attained significant reductions in BMI compared with those in the placebo group, a study found. Improvements in fasting glucose, alanine aminotransferase and adiponectin-to-leptin ratio were also seen in metformin-treated patients, researchers noted. The findings appear in the Journal of Clinical Endocrinology & Metabolism.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR